Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial.
Goossens ME, Zeegers MP, van Poppel H, Joniau S, Ackaert K, Ameye F, Billiet I, Braeckman J, Breugelmans A, Darras J, Dilen K, Goeman L, Tombal B, Van Bruwaene S, Van Cleyenbreugel B, Van der Aa F, Vekemans K, Buntinx F.
Goossens ME, et al. Among authors: braeckman j.
Eur J Cancer. 2016 Dec;69:9-18. doi: 10.1016/j.ejca.2016.09.021. Epub 2016 Oct 29.
Eur J Cancer. 2016.
PMID: 27814472
Clinical Trial.